Safety and Efficacy of Aliskiren in the Treatment of Hypertension and Associated Clinical Conditions
Fabio Angeli(University of Insubria), Paolo Verdecchia(Azienda Ospedaliera di Perugia), Marta Garofoli(University of Perugia), Gianpaolo Reboldi(Ca' Foncello Hospital), Cristina Poltronieri(ASM Terni (Italy)), Alessandra Biadetti, Giovanni Mazzotta(University of Perugia), Elisa Ramundo(University of Perugia)
Cited by 21
Related Papers
European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring
|Journal of Hypertension|2013|1.4k
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
|European Journal of Internal Medicine|2020|1.3k
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring
|Journal of Hypertension|2014|1k
Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects
|Hypertension|2004|506
Prognostic Effect of the Nocturnal Blood Pressure Fall in Hypertensive Patients
|Hypertension|2016|503